Production, Development and Theranostic Applications of Radiopharmaceuticals for Nuclear Medicine
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Radiopharmaceutical Sciences".
Deadline for manuscript submissions: 25 April 2025 | Viewed by 326
Special Issue Editors
Interests: medical physics; biophysics; nuclear medicine; radiology; radiation protection
Interests: nuclear medicine; biophysics; oncology; radiotracers
Interests: drug evaluation, preclinical; molecular imaging; positron-emission tomography; radioactive tracers; radiochemistry
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Theranostics is an innovative method that integrates diagnostic imaging with radionuclide treatment. There has been a significant growth in the use of theranostics in nuclear medicine clinical practice in recent years. As a result, research has been concentrated on finding new radionuclides that can attach to specific molecular targets that are commonly dysregulated in various types of cancer. The theranostic technique offers several significant benefits, such as streamlining treatments, minimizing harm to healthy tissues, enabling early diagnosis, improving predicting responses, and providing individualized patient therapy.
This Special Issue aims to discuss the current state of the art and progress in this field. Research areas may include (but are not limited to) the following: emerging theranostic molecules, recently introduced molecular targets, and production and development of new radiopharmaceuticals for theranostic applications.
Dr. Vlad Ghizdovat
Dr. Cipriana Stefanescu
Dr. Cécile Philippe
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- theranostic
- radiopharmaceuticals
- nuclear medicine
- alpha-emitting radioisotopes
- beta-emitting radioisotopes
- gamma-emitting radioisotopes
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
